Archivio Categoria: venture capital funding

Systm Foods Acquires HUMM Kombucha

USA – Systm Foods, a Newport Beach, CA-based provider of a functional beverage brand platform, acquired HUMM Kombucha, a Bend, OR-based company working in the field of a low and zero-sugar kombucha and gut health beverage category. The amount of the deal was not disclosed.HUMM will be part of the Systm brands portfolio, alongside plant-powered […]

SonicWall Acquires Banyan Security

USA – SonicWall, a Milpitas, CA-based cybersecurity company, acquired Banyan Security, a San Francisco, CA-based provider of security service edge (SSE) solutions for the modern workforce. The amount of the deal was not disclosed.This acquisition strengthens SonicWall’s portfolio by adding zero trust security used by Fortune 100 companies to small businesses who are replacing legacy […]

Graviton Bioscience Closes Funding

USA – Graviton Biosciences, a NYC-based biotechnology company, raised an undisclosed amount in funding. Enavate Sciences, a portfolio company of Patient Square Capital, made the investment. The company intends to use the funds to advance clinical development of GV101 and its pipeline of ROCK2 inhibitors to treat a range of serious fibrotic, inflammatory and neurologic conditions.Led by […]

iFlock Security Consulting Raises Funding

USA – iFlock Security Consulting, a Wakarusa, IN-based boutique cybersecurity company, raised an undisclosed amount in funding. The backers were not disclosed.The funding will support the company’s continued growth and investment in its workforce, infrastructure, and research and development. Led by president Derek Odiorne, iFlock Security Consulting is a boutique cybersecurity company specializing in penetration […]

Travelport Closes Equity Financing

UK – Travelport, a Langley, UK-based technology company that empowers travel bookings for travel suppliers, completed its previously announced financing transaction with a group of its existing equity holders and lenders who have invested $570m in new equity into the company. Travelport’s owners are now composed of existing equity and credit investors, including Elliott Investment Management, […]

Radionetics Oncology Closes $52.5M Series A Financing

Radionetics Oncology, a San Diego, CA-based clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, raised $52.5M in Series A funding. The round, which brought the total amount to $82.5M, was led by Frazier Life Sciences, 5AM Ventures, and new investor, DCVC Bio, […]

Aqua Security Secures $60M in Funding

USA – Aqua Security, a Boston, MA- and Ramat Gan, IL-based company which specializes in cloud native security, raised $60M in funding. The funding, an extension of the company’s Series E round, places Aqua’s valuation above $1B.  The round was led by Evolution Equity Partners, with participation from existing investors Insight Partners, Lightspeed Venture Partners and […]

Vita Inclinata Technologies Closes $44M Round

USA – Vita Inclinata Technologies, a Broomfield, CO-based company which specializes in intelligent lifting hardware and software for rescue crews and other field safety applications, raised $44M in funding. The round saw participation from 3&1 Fund.The company intends to use the funds to accelerate its growth and expansion.Led by Caleb Carr, President and CEO, Vita […]

Remix Therapeutics Closes $60M Financing

USA – Remix Therapeutics, a Cambridge, MA-based clinical-stage biotechnology company developing small molecule therapies, raised $60M in funding. The round was led by The Column Group with participation from existing investors Atlas Venture, Foresite Capital, Alexandria Venture Investments, Arch Venture Partners, Casdin Capital, and Surveyor along with new investors WTT Investment, Willett Advisors, and others. […]

BioCentriq Raises $29.2M in Series A Funding

USA – BioCentriq, a Newark, NJ-based cell-based therapy contract development and manufacturing organization (CDMO), raised $29.2M in Series A funding. The backers were not disclosed.The company intends to use the funds to enhance its facilities, invest in advanced technologies, and expand its team.Led by CEO James Park, BioCentriq specializes in cell therapy contract development and […]